Advaxis | Evaluate

Asco 2021 movers – PDS wins, but big pharma reigns

PDS and Spectrum rise, while Black Diamond, Alpine, Harpoon and Macrogenics disappoint, and others ride on big pharma’s coattails.

February 12, 2020

Asco-GU 2020: revving up for Peloton deal validation

The meeting’s abstracts point to studies from Merck & Co, Exelixis and others that should be on investors’ radar.

December 19, 2019

Gene therapy clinical holds take centre stage

An analysis of company disclosures reveals a sharp rise in US FDA-imposed halts on clinical work involving gene therapies.

January 24, 2019

Advaxis faces a long road back after third Axal hold

September 18, 2017

Corrected: Weekly Market Movers: Global Majors & Industry (to 15 Sep 2017)

November 25, 2016

Snippet roundup: The eyes have it for Allergan but not Novartis

October 24, 2016

Second time around, Aduro fails to shake off the listeria

August 11, 2016

The stakes rise for unpartnered assets

August 05, 2016

Snippet roundup: Biogen buy rumours, CVS cuts and Spark gains on Shire's loss,

June 23, 2016

Valuable late-stage pipeline sets 2017 up for some big events

March 18, 2016

AACR preview – Novel targets in the spotlight

Load More